Literature DB >> 28031453

Acute Liver Failure Meets SOPH Syndrome: A Case Report on an Intermediate Phenotype.

Fanny Kortüm1, Iris Marquardt2, Malik Alawi3,4,5, Georg Christoph Korenke2, Stephanie Spranger6, Peter Meinecke1, Kerstin Kutsche7.   

Abstract

Acute liver failure (ALF) is a life-threatening condition in the absence of preexisting liver disease in children. The main clinical presentation comprises hepatic dysfunction, elevated liver biochemical values, and coagulopathy. The etiology of ALF remains unclear in most affected children; however, the recent identification of mutations in the neuroblastoma amplified sequence (NBAS) gene in autosomal recessively inherited ALF has shed light on the cause of a subgroup of fever-triggered pediatric ALF episodes. Previously, biallelic mutations in NBAS have been reported to be associated with a syndrome comprising short stature, optic atrophy, and Pelger-Huët anomaly (SOPH) specifically occurring in the Yakut population. No hepatic phenotype has been observed in individuals with this disorder who all carry the homozygous NBAS founder mutation c.5741G>A [p.(Arg1914His)]. We present the case of a 4-year-old girl with the cardinal features of SOPH syndrome: characteristic facial dysmorphism, postnatal growth retardation, delay of bone age, slender long bones, optic atrophy, and Pelger-Huët anomaly. During the first 2 years of her life, a series of infections with episodes of fever were accompanied by elevated liver enzyme levels, but hyperammonemia, hypoglycemia, coagulopathy, or encephalopathy suggestive of acute and severe liver disease were never observed. Whole exome sequencing in the patient revealed compound heterozygosity of the 2 NBAS variants, p.(Arg1914His) and p.(Glu943*). This case highlights the variability of clinical presentation associated with NBAS deficiency. Absence of severe liver problems in this case and SOPH-affected Yakut subjects suggests that individuals carrying the NBAS missense mutation p.(Arg1914His) are less susceptible to developing ALF.
Copyright © 2017 by the American Academy of Pediatrics.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28031453     DOI: 10.1542/peds.2016-0550

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  8 in total

1.  Defining clinical subgroups and genotype-phenotype correlations in NBAS-associated disease across 110 patients.

Authors:  Christian Staufner; Bianca Peters; Matias Wagner; Seham Alameer; Ivo Barić; Pierre Broué; Derya Bulut; Joseph A Church; Ellen Crushell; Buket Dalgıç; Anibh M Das; Anke Dick; Nicola Dikow; Carlo Dionisi-Vici; Felix Distelmaier; Neslihan Ekşi Bozbulut; François Feillet; Emmanuel Gonzales; Nedim Hadzic; Fabian Hauck; Robert Hegarty; Maja Hempel; Theresia Herget; Christoph Klein; Vassiliki Konstantopoulou; Robert Kopajtich; Alice Kuster; Martin W Laass; Elke Lainka; Catherine Larson-Nath; Alexander Leibner; Eberhard Lurz; Johannes A Mayr; Patrick McKiernan; Karine Mention; Ute Moog; Neslihan Onenli Mungan; Korbinian M Riedhammer; René Santer; Irene Valenzuela Palafoll; Jerry Vockley; Dominik S Westphal; Arnaud Wiedemann; Saskia B Wortmann; Gaurav D Diwan; Robert B Russell; Holger Prokisch; Sven F Garbade; Stefan Kölker; Georg F Hoffmann; Dominic Lenz
Journal:  Genet Med       Date:  2019-11-25       Impact factor: 8.822

2.  NBAS mutations cause acute liver failure: when acetaminophen is not a culprit.

Authors:  Pier Luigi Calvo; Francesco Tandoi; Tobias B Haak; Andrea Brunati; Michele Pinon; Dominic Dell Olio; Renato Romagnoli; Marco Spada
Journal:  Ital J Pediatr       Date:  2017-09-25       Impact factor: 2.638

3.  Novel NBAS mutations and fever-related recurrent acute liver failure in Chinese children: a retrospective study.

Authors:  Jia-Qi Li; Yi-Ling Qiu; Jing-Yu Gong; Li-Min Dou; Yi Lu; A S Knisely; Mei-Hong Zhang; Wei-Sha Luan; Jian-She Wang
Journal:  BMC Gastroenterol       Date:  2017-06-19       Impact factor: 3.067

4.  Novel neuroblastoma amplified sequence (NBAS) mutations in a Japanese boy with fever-triggered recurrent acute liver failure.

Authors:  Sahoko Ono; Junko Matsuda; Etsuko Watanabe; Hiroto Akaike; Hideto Teranishi; Ippei Miyata; Takanobu Otomo; Yoshito Sadahira; Tatsuki Mizuochi; Hironori Kusano; Masayoshi Kage; Hiroo Ueno; Kenichi Yoshida; Yuichi Shiraishi; Kenichi Chiba; Hiroko Tanaka; Satoru Miyano; Seishi Ogawa; Yasuhide Hayashi; Hirokazu Kanegane; Kazunobu Ouchi
Journal:  Hum Genome Var       Date:  2019-01-07

5.  Recurrent acute liver failure associated with novel SCYL1 mutation: A case report.

Authors:  Jia-Qi Li; Jing-Yu Gong; A S Knisely; Mei-Hong Zhang; Jian-She Wang
Journal:  World J Clin Cases       Date:  2019-02-26       Impact factor: 1.337

6.  Resolution of recurrent pediatric acute liver failure with liver transplantation in a patient with NBAS mutation.

Authors:  Duke Geem; Wenxiao Jiang; Heather B Rytting; Shanmuganathan Chandrakasan; Anand Salem; James P Stevens; Saul J Karpen; Joseph F Magliocca; Rene Romero; Dellys Soler Rodriguez
Journal:  Pediatr Transplant       Date:  2021-07-20

Review 7.  Immunological Features of Neuroblastoma Amplified Sequence Deficiency: Report of the First Case Identified Through Newborn Screening for Primary Immunodeficiency and Review of the Literature.

Authors:  Silvia Ricci; Lorenzo Lodi; Daniele Serranti; Marco Moroni; Gilda Belli; Giorgia Mancano; Andrea La Barbera; Giulia Forzano; Giusi Mangone; Giuseppe Indolfi; Chiara Azzari
Journal:  Front Immunol       Date:  2019-08-27       Impact factor: 7.561

8.  Infantile fever-triggered acute liver failure caused by novel neuroblastoma amplified sequence mutations: a case report.

Authors:  Weiran Li; Yu Zhu; Qin Guo; Chaomin Wan
Journal:  BMC Gastroenterol       Date:  2020-09-21       Impact factor: 3.067

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.